Skip to content

EEG characteristics of transcutaneous electrical acupoint stimulation in the treatment of pain after thoracoscopic lobectomy : a randomized controlled trial

EEG characteristics of transcutaneous electrical acupoint stimulation in the treatment of pain after thoracoscopic lobectomy : a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107322
Enrollment
Unknown
Registered
2025-08-08
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thoracic surgery

Interventions

TEAS treatment group:The patients ' bilateral Zusanli, Neiguan, Hegu, Houxi and Zhigou points were stimulated by transcutaneous acupoint electrical stimulation for 30 min, and 10 min EEG was collected
control group:none
TEAS after treatment group:The patients ' bilateral Zusanli, Neiguan, Hegu, Houxi and Zhigou points were stimulated by transcutaneous acupoint electrical stimulation for 30 min, and then 10 min EEG wa

Sponsors

Xuzhou Central Hospital, Jiangsu Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: ( 1 ) Age between 18-60 years old, regardless of gender ; ( 2 ) ASA grade I to II ; ( 3 ) Patients undergoing thoracoscopic lobectomy ; ( 4 ) Antidepressants, anti-anxiety drugs or any analgesic drugs were not used within 2 weeks before surgery ; ( 5 ) agreed to participate in this study and signed informed consent .

Exclusion criteria

Exclusion criteria: ( 1 ) suffering from mental or neurological diseases ( such as cognitive dysfunction, epilepsy ) ; ( 2 ) Patients with severe heart problems such as unstable angina pectoris and recent myocardial infarction. ( 3 ) cardiac pacemaker or other metal implants ; ( 4 ) patients with skin lesions in the area where the electrode patch is placed, such as acute skin infection, rash, ulcer or other skin damage ; ( 5 ) Patients with hemorrhagic disease or undergoing anticoagulant therapy. ( 6 ) Allergic or intolerant to electrical stimulation ; ( 7 ) pregnant or lactating women .

Design outcomes

Primary

MeasureTime frame
Electroencephalogram;numerical rating scales;

Secondary

MeasureTime frame
self-rating anxiety scale;athens insomnia scale;

Countries

China

Contacts

Public ContactLiu Songtao

Xuzhou Central Hospital, Jiangsu Province

liusongtao0505@163.com+86 139 5218 7377

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026